![Deborah Charych](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Deborah Charych
Director/Board Member at
SKYE BIOSCIENCE, INC.
Net worth: - $ as of 31/07/2026
Profile
Deborah Charych is the founder of Third Rock Ventures LP, founded in 2017.
Dr. Charych was the founder of Rayzebio, Inc., founded in 2018, and served as Chief Technology Officer from 2018 to 2022.
Dr. Charych is also the founder of Maze Therapeutics, Inc...
Dr. Charych is Chief Executive Officer, CFO & Secretary at Utter Therapeutics, Inc. Dr. Charych is Independent Director at Skye Bioscience, Inc. since 2023.
Dr. Charych was Director-Preclinical & Translational Research at Nektar Therapeutics from 2010 to 2018.
Dr. Charych was Director-Biologics Process Development at Five Prime Therapeutics, Inc. from 2007 to 2010.
Dr. Charych completed undergraduate studies at Carnegie Mellon University.
Dr. Charych earned a doctorate from the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Deborah Charych active positions
| Companies | Position | Start |
|---|---|---|
| SKYE BIOSCIENCE, INC. | Director/Board Member | 14/02/2023 |
Former positions of Deborah Charych
| Companies | Position | End |
|---|---|---|
| RAYZEBIO, INC. | Founder | 01/09/2022 |
Third Rock Ventures LP
 Third Rock Ventures LP Investment ManagersFinance Acts as Venture Capital Fund | Founder | 01/01/2019 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01/01/2018 |
| FIVE PRIME THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2010 |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Founder | - |
Training of Deborah Charych
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
54
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Third Rock Ventures LP
Third Rock Ventures LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skye Bioscience, Inc.
 Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Health Technology |
Rayzebio, Inc.
 Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
- Stock Market
- Insiders
- Deborah Charych
